PT906100E - Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria - Google Patents

Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria

Info

Publication number
PT906100E
PT906100E PT97906125T PT97906125T PT906100E PT 906100 E PT906100 E PT 906100E PT 97906125 T PT97906125 T PT 97906125T PT 97906125 T PT97906125 T PT 97906125T PT 906100 E PT906100 E PT 906100E
Authority
PT
Portugal
Prior art keywords
treatment
affinity
utilization
receptor antagonists
urinary incontinence
Prior art date
Application number
PT97906125T
Other languages
English (en)
Inventor
Rodolfo Testa
Amedeo Leonardi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT906100(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of PT906100E publication Critical patent/PT906100E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97906125T 1996-02-28 1997-02-25 Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria PT906100E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria

Publications (1)

Publication Number Publication Date
PT906100E true PT906100E (pt) 2004-06-30

Family

ID=11373430

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97906125T PT906100E (pt) 1996-02-28 1997-02-25 Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria

Country Status (10)

Country Link
EP (1) EP0906100B1 (pt)
JP (1) JP2001511763A (pt)
AT (1) ATE258438T1 (pt)
AU (1) AU2093297A (pt)
DE (1) DE69727378T2 (pt)
DK (1) DK0906100T3 (pt)
ES (1) ES2213205T3 (pt)
IT (1) IT1282705B1 (pt)
PT (1) PT906100E (pt)
WO (1) WO1997031637A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
SE510305C2 (sv) 1997-05-30 1999-05-10 Astra Ab Nytt salt
WO1999003833A1 (fr) * 1997-07-15 1999-01-28 Sankyo Company, Limited Derives de piperazine
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
WO2001060818A1 (en) * 2000-02-14 2001-08-23 Tularik Inc. Lxr modulators
US6673543B2 (en) 2000-04-05 2004-01-06 Tularik, Inc. Solid phase synthesis of LXR ligands
ES2275853T3 (es) * 2001-02-16 2007-06-16 Aventis Pharmaceuticals Inc. Derivados heterociclicos de urea y su uso como ligandos de receptores de dopamina d3.
EP1438035A2 (en) * 2001-09-27 2004-07-21 Pharmacia AB Pharmaceutical compositions for the treatment of urinary disorders
AU2003208952B2 (en) 2002-01-30 2008-04-24 Amgen Inc. Heterocyclic arylsulfonamidobenzylic compounds
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
US20080119518A1 (en) * 2005-02-04 2008-05-22 Yuichi Suzuki 1-(Piperidin-4- Yl)-1H-Indole Derivatives
EP1880995B1 (en) 2005-05-11 2011-12-21 Eisai R&D Management Co., Ltd. Method for producing indole derivative having piperidine ring

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd Piperazine derivatives their preparation and pharmaceutical compositions containing them
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method

Also Published As

Publication number Publication date
WO1997031637A1 (en) 1997-09-04
AU2093297A (en) 1997-09-16
EP0906100A1 (en) 1999-04-07
EP0906100B1 (en) 2004-01-28
JP2001511763A (ja) 2001-08-14
IT1282705B1 (it) 1998-03-31
ITMI960378A0 (pt) 1996-02-28
DE69727378D1 (de) 2004-03-04
ITMI960378A1 (it) 1997-08-28
ES2213205T3 (es) 2004-08-16
DE69727378T2 (de) 2004-12-09
DK0906100T3 (da) 2004-05-03
ATE258438T1 (de) 2004-02-15

Similar Documents

Publication Publication Date Title
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
AU9648098A (en) Adenosine a3 receptor antagonists
DK0906100T3 (da) Anvendelse af 5-HT1A-receptorantagonister til behandling af urininkontinens
ATE234290T1 (de) Phenylalkyl-imidazole als h3-rezeptor- antagonisten
AU7406596A (en) Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use
DE69706407D1 (de) META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN
BR1100680A (pt) Antagonistas tricìclos de receptores de 5-ht3
LV11688A (lv) Morfolina tahikinina receptoru antagonistu priekstecvielas
ATE219764T1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
EP1762236A3 (en) Formulations of alpha adrenergic receptor antagonists and their uses
HRP20010119B1 (hr) Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
PT808318E (pt) Antagonistas adrenergicos triciclos alfa-1 de hexa-hidrobenz¬e|isoindolo substituido
ES2173172T3 (es) Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
AR017296A1 (es) Uso de un antagonista del receptor de 5-hidroxitriptamina y compuestos antagonistas
DK1129091T3 (da) Antagonister for CRF-receptorer og fremgangsmåder med relation dertil
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
WO1997010824A8 (en) Use of 5ht1b receptor antagonist for the treatment of vascular disease
CA2133106A1 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
BR0007864A (pt) Composto, e, uso de um composto
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
IT1304499B1 (it) Procedimento per ridurre il peso molecolare di copolimeri eterpolimeri dell'etilene.
ATE174327T1 (de) Bicyclo (2.2.2) oktan-derivate mit cholecystokinin und/oder gastrin antagonistischer wirkung
FR2702150B1 (fr) Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
IT1270612B (it) Derivati eterociclo-condensatori di morfinoidi